List of works - Ruth Broering

Advanced Method for Isolation of Mouse Hepatocytes, Liver Sinusoidal Endothelial Cells, and Kupffer Cells.

scientific article published on January 2017

All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells

scientific article published on 25 September 2015

B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes

scientific article published on 26 December 2012

Controversial: Early Innate Responses to Hepatitis B Virus Infection, an Explanation for Viral Persistence?

scientific article published on 06 July 2020

Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state

article

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy

scientific article published on 23 March 2017

Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infection.

scientific article published on February 2016

Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes

scientific article published on 11 January 2020

Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection

scientific article published on 25 May 2021

Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication

scientific article published on December 2013

Inducible Rubicon facilitates viral replication by antagonizing interferon production

scientific article published on 10 April 2017

Intrahepatic B-cell follicles of chronically hepatitis C virus-infected individuals lack signs of an ectopic germinal center reaction.

scientific article published on 14 April 2014

KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.

scientific article published on 26 April 2014

Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity

scientific article published on 23 November 2019

MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver.

scientific article published on 11 September 2013

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.

scientific article published on 19 May 2012

Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections

article

Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.

scientific article published on 19 May 2012

Role of Toll-like receptors in liver health and disease ⬇️

scientific article published on November 1, 2011

Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway.

scientific article

Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological Processes

scientific article published on 17 April 2020

TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production

scientific article published on 19 February 2018

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

scientific article

Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection

scientific article published on 11 November 2015

Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.

scientific article

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

scientific article published on 01 December 2007

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.

scientific article

List of works by Ruth Broering

Advanced Method for Isolation of Mouse Hepatocytes, Liver Sinusoidal Endothelial Cells, and Kupffer Cells.

All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells

B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes

Controversial: Early Innate Responses to Hepatitis B Virus Infection, an Explanation for Viral Persistence?

Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy

Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infection.

Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes

Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection

Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication

Inducible Rubicon facilitates viral replication by antagonizing interferon production

Intrahepatic B-cell follicles of chronically hepatitis C virus-infected individuals lack signs of an ectopic germinal center reaction.

KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.

Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity

MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver.

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.

Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections

Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.

Role of Toll-like receptors in liver health and disease ⬇️

Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway.

Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological Processes

TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection

Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.